bromocriptine has been researched along with nafadotride in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azaryan, AV; Clock, BJ; Cox, BM | 1 |
Canales, JJ; Iversen, SD | 1 |
Floresco, SB; St Onge, JR | 1 |
3 other study(ies) available for bromocriptine and nafadotride
Article | Year |
---|---|
Mu opioid receptor mRNA in nucleus accumbens is elevated following dopamine receptor activation.
Topics: Animals; Benzazepines; Bromocriptine; Cocaine; Dopamine Antagonists; Male; Naphthalenes; Nucleus Accumbens; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Opioid, mu; RNA, Messenger; Salicylamides; Transcription, Genetic; Up-Regulation | 1996 |
Psychomotor-activating effects mediated by dopamine D(2) and D(3) receptors in the nucleus accumbens.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Benzopyrans; Bromocriptine; Grooming; Indoles; Motor Activity; Naphthalenes; Nucleus Accumbens; Oxazines; Piperidines; Pyrrolidines; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3 | 2000 |
Dopaminergic modulation of risk-based decision making.
Topics: Animals; Behavior, Animal; Benzamides; Benzazepines; Benzopyrans; Bromocriptine; Conditioning, Operant; Decision Making; Dextroamphetamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Naphthalenes; Oxazines; Piperazines; Pyridines; Pyrroles; Pyrrolidines; Rats; Rats, Long-Evans; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4; Reinforcement Schedule; Risk; Salicylamides | 2009 |